Former CIA Director John Brennan has sued the Trump administration, demanding a court order that would require officials to preserve records from investigations he says are targeting him for “what amounts to phantom criminal conduct.” The lawsuit says the records would shed light on the motivations of government officials who are investigating Brennan. Meanwhile, President Donald Trump visited North Dakota on Wednesday to see the newly built Theodore Roosevelt Presidential Library, built in the rugged, lonely landscape where Roosevelt built his conservation values in the 1880s.
The Trump administration has warned more than 500 hospitals that they are failing to provide the public with enough information about prices. And the administration argues the lack of disclosure is keeping healthcare costs higher than they should be. The Associated Press exclusively obtained the list of hospitals that have received letters on the issue since April. Failing to comply with the warnings comes with penalties as high as $2 million a year. The letters are part of a push to do more to enforce price transparency standards that President Donald Trump established in his first term. They come as Trump is trying to show people he's addressing cost of living concerns ahead of the November midterm elections.
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay. In doing so, he incorrectly placed the blame for the high prices on foreign nations. The AP examined the facts.
Some cancer patients are hitting coverage limits on a cheap anti-nausea pill that can ward off waves of vomiting after treatment. Doctors say restrictions on the number of tablets can hurt care. Pharmacy benefit managers say their restrictions guard against overuse. In between sits patients. They may have to ration pills or opt for less-effective help. The conflict offers a glimpse at how relatively simple acts of care can grow complex in the fragmented U.S. health care system.
The Biden administration says Medicare recipients will save about $1.5 billion dollars on medications to for diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026. The savings range from 79% for Januvia, a drug to treat diabetes to 38% for Imbruvica, which is used to treat blood cancers. That is the medication’s cost before any discounts or rebates are applied, but not what the price people actually pay when filling their prescriptions.